SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: WTDEC who wrote (29385)11/13/1999 10:01:00 AM
From: Henry Niman  Read Replies (4) | Respond to of 32384
 
Fenretmide is not one of LGND's compounds. It's in several trials for several malignancies, all of which are sponsored by the government. The drug is a derivative of all trans retinoic acid
ncbi.nlm.nih.gov
Not sure if it has been licensed to any company. In animal studies, Panretin and Targretin appear to be more potent.